Non-alcoholic fatty liver disease (NAFLD), now reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging as a major health concern among young Indians, especially ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Liver disease is no longer confined to alcohol abuse. There is a worrying rise in non-alcoholic fatty liver disease. Experts reveal how to fix it fast.